Article

Statistical Decision Properties of Imprecise Trials Assessing COVID-19 Drugs

2020-06-05

Abstract excerpt

As the COVID-19 pandemic progresses, researchers are reporting findings of randomized trials comparing standard care with care augmented by experimental drugs. The trials have small sample sizes, so estimates of treatment effects are imprecise. Seeing imprecision, clinicians reading research articles may find it difficult to decide when to treat patients with experimental drugs. Whatever decision criterion one use...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: cb59e5d2-5efd-5cf8-8655-5f0addaf2a9f
DOI: 10.1101/2020.05.26.20114009

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Statistical Decision Properties of Imprecise Trials Assessing COVID-19 DrugsDOI 10.1101/2020.05.26.20114009Read

The Call for Progress in Evidence-Based MedicineSemantic proximity Read

Treatment recommendations based on Network Meta-Analysis: rules for risk-averse decision-makersSemantic proximity Read

P-hacking in clinical trials and how incentives shape the distribution of results across phases<sup>*</sup>Semantic proximity Read

COVID-19: Why SOLIDARITY and DisCoVeRy trials may fail to bring informative and timely resultsSemantic proximity Read

Challenges and Lessons Learned from COVID-19 Trials – Should We be Doing Clinical Trials Differently?Semantic proximity Read

Communicating the Robustness of Findings of COVID-19 StudiesSemantic proximity Read

Real World Evidence – Current Developments and PerspectivesSemantic proximity Read

How precision medicine changes medical epistemology: A formative case from NorwaySemantic proximity Read

Methodological Analysis of Bias Risks in Adaptive Multi-Arm Platform Trials: A Case-Series from Three COVID-19 StudiesSemantic proximity Read

Randomized Controlled Trials Versus Real World Evidence: Neither Magic Nor Myth.Semantic proximity Read

Project Rebuild the Evidence Base (REB): a method to interpret randomised clinical trials and their meta-analysis to present solid benefit-risk assessments to patients.Semantic proximity Read

Metformin at the time of Covid-19 infection and risk of Long Covid: A Target Trial Emulation StudySemantic proximity Read